Amarantus Bioscience Holdings Inc (AMBS)

[Dr Jerry]

I was very disappointed that Ceregene's phase 2 trial failed to achieve statistical significance .
It was terribly frustrating for doctors and patients alike because many had anticipated and hoped for a major breakthrough in Parkinsons's disease since the Amgen GDNF fiasco .
However, there are several great points to ponder for Gerald and AMBS.
MJFF specifically mentioned MANF by name as possible contender for clinical development and I think funds from the foundation are coming.
Second, Gerald has stuck to his guns by moving ahead with delivery of MANF using CED and micro catheters versus viral vectors. Expect a jv with nsGene or similar company that uses microcathters.
Thirdly, Gerald keeps adding key personnel to guide AMBS towards success.
Fourth, I was pleased to see that AMBS diagnostics has obtained a new test for breast cancer and is beginning to branch out into other areas like oncology.
I want to see progress in uplisting to AMEX and would accept grudgingly a reverse split to get it done just to get out of penny land where to much manipulation occurs. so easily.
I would love to see that short squeeze happen that has been predicted by many here.
Go AMBS